Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GSTS Celebrate Success of Inaugural Scientific Symposium and Launch Innovation Academy

Published: Thursday, July 11, 2013
Last Updated: Thursday, July 11, 2013
Bookmark and Share
GSTS recently hosted their first Innovation Academy event in London (28 June 2013).

This inaugural scientific symposium welcomed over 100 attendees, offering participants great networking opportunities and the chance to hear presentations from a group of GSTS experts.

Discussions were focused into four tracks – child health, keeping people healthy, infectious diseases, and next-generation diagnostics – and on-show was the innovative approach to laboratory medicine that can be found throughout the GSTS organisation.

GSTS_Photo.gifDr Dominic Harrington, Scientific Director, and co-chair of the event, said, “Clinical science is part of the fabric of GSTS, and the scientists presenting here today continue to make significant contributions to the further development of best-practice in clinical pathology. The Innovation Academy event allowed us to share, celebrate and support the contributions of our staff. We were delighted to see the turnout on the day and look forward to the next one.”


As the UK's leading independent provider of pathology services, GSTS and King's College Pathology LLP provide pathology services that make a real difference to patient care. The Innovation Academy was organised to create an environment to support innovation, quality and the development of future scientific leaders. Dr Harrington said “Today is about the scientists being heard. We have broken the science into four broad themes to help make potentially higher level science more accessible to the decision makers and executive teams, as well as for our users. This enables us to articulate the value that scientists bring to patients, medics, and to the GSTS organisation.”

Drawing from twelve senior scientists across the GSTS and KingsPath partnership, the presentations covered current trends and topical developments in areas such as expanded newborn screening, vitamin B12 deficiency, HIV drug resistance and pre-implantation genetic diagnosis. Dr Harrington said “Underneath today’s themes is some real high end science and this has come across because, after all, a subject matter expert is always the best person to articulate the enthusiasm for that area”.

Dr Harrington added, “There is currently a direction towards consolidation of laboratory services and this is a challenge, so having an event such as this where the collaboration can come together really helps partners learn and understand each others’ expertise.

The next event in the series is planned for 6th December 2013.

To find out more about innovation at GSTS and KingsPath, please visit: www.gsts.com


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!